97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details


臨床試験数 : 2,630 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

  
6 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2020-003017-35-LV
(EUCTR)
29/07/202117/03/2021A study of LY3471851 in adult participants with moderately to severely active ulcerative colitis (UC)An Adaptive Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY3471851 (NKTR-358) in Patients with Moderately to Severely Active Ulcerative Colitis - INSTRUCT-UC Ulcerative Colitis
MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: LY3471851
Product Code: LY3471851
INN or Proposed INN: LY3471851
Eli Lilly and CompanyNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
200Phase 2United States;Czechia;Slovakia;Ukraine;Israel;Russian Federation;United Kingdom;India;France;Czech Republic;Hungary;Canada;Argentina;Poland;Belgium;Brazil;Romania;Australia;Georgia;Germany;Latvia;China;Japan;Korea, Republic of
2EUCTR2020-003017-35-SK
(EUCTR)
26/05/202128/12/2020A study of LY3471851 in adult participants with moderately to severely active ulcerative colitis (UC)An Adaptive Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY3471851 (NKTR-358) in Patients with Moderately to Severely Active Ulcerative Colitis - INSTRUCT-UC Ulcerative Colitis
MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: LY3471851
Product Code: LY3471851
INN or Proposed INN: LY3471851
Eli Lilly and CompanyNULLNot RecruitingFemale: yes
Male: yes
200Phase 2United States;Czechia;Slovakia;Ukraine;Russian Federation;Israel;United Kingdom;India;France;Czech Republic;Hungary;Canada;Argentina;Belgium;Poland;Brazil;Romania;Australia;Georgia;Germany;Latvia;China;Japan;Korea, Republic of
3EUCTR2020-003017-35-PL
(EUCTR)
25/05/202115/02/2021A study of LY3471851 in adult participants with moderately to severely active ulcerative colitis (UC)An Adaptive Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY3471851 (NKTR-358) in Patients with Moderately to Severely Active Ulcerative Colitis - INSTRUCT-UC Ulcerative Colitis
MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: LY3471851
Product Code: LY3471851
INN or Proposed INN: LY3471851
Eli Lilly and CompanyNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
200Phase 2United States;Czechia;Slovakia;Ukraine;Israel;Russian Federation;United Kingdom;India;France;Czech Republic;Hungary;Canada;Argentina;Belgium;Poland;Brazil;Romania;Australia;Georgia;Latvia;Germany;China;Japan;Korea, Republic of
4EUCTR2020-003017-35-BE
(EUCTR)
15/04/202105/02/2021A study of LY3471851 in adult participants with moderately to severely active ulcerative colitis (UC)An Adaptive Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY3471851 (NKTR-358) in Patients with Moderately to Severely Active Ulcerative Colitis - INSTRUCT-UC Ulcerative Colitis
MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: LY3471851
Product Code: LY3471851
INN or Proposed INN: LY3471851
Eli Lilly and CompanyNULLNot RecruitingFemale: yes
Male: yes
200Phase 2United States;Czechia;Slovakia;Ukraine;Israel;Russian Federation;United Kingdom;India;France;Czech Republic;Hungary;Canada;Argentina;Poland;Belgium;Brazil;Romania;Australia;Georgia;Latvia;Germany;China;Japan;Korea, Republic of
5EUCTR2020-003017-35-CZ
(EUCTR)
04/03/202129/12/2020A study of LY3471851 in adult participants with moderately to severely active ulcerative colitis (UC)An Adaptive Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY3471851 (NKTR-358) in Patients with Moderately to Severely Active Ulcerative Colitis - INSTRUCT-UC Ulcerative Colitis
MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: LY3471851
Product Code: LY3471851
INN or Proposed INN: LY3471851
Eli Lilly and CompanyNULLNot RecruitingFemale: yes
Male: yes
200Phase 2United States;Czechia;Slovakia;Ukraine;Russian Federation;Israel;United Kingdom;India;France;Czech Republic;Hungary;Canada;Argentina;Poland;Belgium;Brazil;Romania;Australia;Georgia;Latvia;Germany;Japan;China;Korea, Republic of
6EUCTR2020-003017-35-HU
(EUCTR)
17/02/202129/12/2020A study of LY3471851 in adult participants with moderately to severely active ulcerative colitis (UC)An Adaptive Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY3471851 (NKTR-358) in Patients with Moderately to Severely Active Ulcerative Colitis - INSTRUCT-UC Ulcerative Colitis
MedDRA version: 20.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: LY3471851
Product Code: LY3471851
INN or Proposed INN: LY3471851
Eli Lilly and CompanyNULLNot RecruitingFemale: yes
Male: yes
200Phase 2United States;Czechia;Slovakia;Ukraine;Russian Federation;Israel;United Kingdom;India;France;Czech Republic;Hungary;Canada;Argentina;Belgium;Poland;Brazil;Romania;Australia;Georgia;Germany;Latvia;China;Japan;Korea, Republic of